These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8544882)
1. [Pharmacology of addiction]. van Ree JM Ned Tijdschr Geneeskd; 1995 Dec; 139(50):2610-3. PubMed ID: 8544882 [No Abstract] [Full Text] [Related]
2. Pharmacology of the central nervous system. Nelson SR; Walaszek EJ Prog Neurol Psychiatry; 1971; 26():123-49. PubMed ID: 4151158 [No Abstract] [Full Text] [Related]
3. Tolerance to, and dependence on, some non-opiate psychotropic drugs. Kalant H; LeBlanc AE; Gibbins RJ Pharmacol Rev; 1971 Sep; 23(3):135-91. PubMed ID: 4398655 [No Abstract] [Full Text] [Related]
4. [Misuse of drugs and excess of self-administered drugs. Problems posed for the pharmacologist]. Jacob J; Barthelemy C Therapie; 1972; 27(2):189-217. PubMed ID: 4404389 [No Abstract] [Full Text] [Related]
5. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents. Commissaris RL; Semeyn DR; Moore KE; Rech RH Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791 [No Abstract] [Full Text] [Related]
6. Drug injections as negative reinforcers. Holz WC; Gill CA Pharmacol Rev; 1975 Sep; 27(3):437-46. PubMed ID: 817314 [No Abstract] [Full Text] [Related]
7. Progress report from the testing program for stimulant and depressant drug (1992). Woolverton WL; Nader MA; Winger G; Woods JH; Patrick GA; Harris LS NIDA Res Monogr; 1993; 132():579-94. PubMed ID: 8101976 [No Abstract] [Full Text] [Related]
8. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. Schifano F; Papanti GD; Orsolini L; Corkery JM Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969 [TBL] [Abstract][Full Text] [Related]
9. [Bioelectric cerebral changes in course of psychiatric treatment]. Seva Díaz A Arch Neurobiol (Madr); 1974; 37(6):545-60. PubMed ID: 4156641 [No Abstract] [Full Text] [Related]
10. Drug addiction: I. A theoretical framework for behavior therapy. Copemann CD Psychol Rep; 1975 Dec; 37(3 Pt 1):947-58. PubMed ID: 704 [No Abstract] [Full Text] [Related]
12. Development of tolerance to and physical dependence on barbiturates in rhesus monkeys. Yanagita T; Takahashi S J Pharmacol Exp Ther; 1970 Mar; 172(1):163-9. PubMed ID: 4984668 [No Abstract] [Full Text] [Related]
13. [Pharmacology of psychic stimulants]. Opitz K Med Monatsschr; 1976 Aug; 30(8):345-50. PubMed ID: 8693 [No Abstract] [Full Text] [Related]
14. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Donovan JL; DeVane CL Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877 [TBL] [Abstract][Full Text] [Related]
15. A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Johanson CE; Balster RL Bull Narc; 1978; 30(3):43-54. PubMed ID: 36945 [No Abstract] [Full Text] [Related]
16. [Prescription and monitoring of psychotropic drugs]. Haffen E; Thibaut F Rev Prat; 2009 Feb; 59(2):267-77. PubMed ID: 19317150 [No Abstract] [Full Text] [Related]
17. Testing for dependence liability of stimulants and depressants in animals and man. Bull Narc; 1977; 29(1):21-31. PubMed ID: 405064 [No Abstract] [Full Text] [Related]
18. Caring for problem drug users. McClelland G Nurs Times; 2006 May 16-22; 102(20):26-8. PubMed ID: 16724604 [TBL] [Abstract][Full Text] [Related]
19. [Neurobiological basis of drug addiction]. Fernández-Espejo E Rev Neurol; 2002 Apr 1-15; 34(7):659-64. PubMed ID: 12080517 [TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Cunha-Oliveira T; Rego AC; Oliveira CR Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]